Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-5.27	-532.20	-505.56
Graham Fair Price	0.01	54.31	54.30
PEG	2887.73	-12.83	0.43
Price/Book	25.42	1.98	1.57
Price/Cash Flow	88.95	29.18	15.44
Prices/Earnings	29.60	10.14	7.83
Price/Sales	26.20	4.76	3.77
Price/FCF	88.95	29.18	15.44
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-19.99	0.80	1.00
Operating Margin	-3.28	0.15	0.16
ROA	-3.05	0.01	0.01
ROE	0.05	0.05	-3.22
ROIC	0.04	0.04	-1.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-0.02
Dividends QOQ	< 0.005	0.10	1136.55
EBIT QOQ	0.23	-0.03	-87.04
EPS QOQ	0.18	< 0.005	-95.66
FCF QOQ	-0.09	-0.33	-263.78
Revenue QOQ	0.04	< 0.005	-92.11
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-2247.40	-100.00
Days Sales Outstanding (DSO)	178.75	183.42	2.61
Inventory Turnover	0.00	-0.04	-100.00
Debt/Capitalization	0.22	0.22	-0.69
Quick Ratio	0.52	0.50	-3.22
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	51.04	51.89	1.66
Cash	18.45	16.15	-12.46
Capex	-0.21	-0.17	21.30
Free Cash Flow	5.20	3.51	-32.52
Revenue	21.31	21.53	1.04
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.33	0.31	-4.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-74.52	-62.17	16.57
Naive Interpretation	Member

06 - Financial Health · Bad

Rating